Related Experiment Video
Updated: Feb 6, 2026

Author Spotlight: Exploring Press Needle Efficacy and Underlying Molecular Pathways
Published on: April 12, 2024
PERSISTENT PLACOID MACULOPATHY IN A PATIENT WITH HIGH MYOPIA.
Anton M Kolomeyer1, Alexander J Brucker
1Department of Ophthalmology, Scheie Eye Institute, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania.
This case report details persistent placoid maculopathy in a patient with high myopia. Early anti-vascular endothelial growth factor (anti-VEGF) therapy and immunosuppression helped control the condition and preserve vision.
Area of Science:
- Ophthalmology
- Retinal Diseases
Background:
- High myopia is a significant risk factor for various ocular pathologies.
- Persistent placoid maculopathy is a rare condition affecting the macula.
Observation:
- A 59-year-old male with high myopia presented with unilateral visual blur.
- Multimodal imaging revealed subretinal thickening and fluid, initially without clear leakage on fluorescein angiography.
- The patient experienced recurrent, bilateral episodes despite initial anti-vascular endothelial growth factor (anti-VEGF) treatment.
Findings:
- Diagnosis of persistent placoid maculopathy was confirmed through multimodal imaging and clinical response.
- The condition exhibited a relapsing-remitting course with bilateral involvement.
- Combination therapy with anti-VEGF injections and immunomodulating agents led to disease quiescence.
Implications:
- Early intervention with anti-VEGF therapy and immunosuppression is crucial for managing persistent placoid maculopathy.
- This approach can lead to disease control and vision preservation in high-myopia patients.
- Multimodal imaging is essential for accurate diagnosis and monitoring of this condition.
Related Concept Videos
Patient-centered Care
Drug Dosing: Geriatric Patients
Drug Dosing: Obese Patients
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution

